Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 54

1.

Trained dogs can identify malignant solitary pulmonary nodules in exhaled gas.

Guirao A, Molins L, Ramón I, Sunyer G, Viñolas N, Marrades R, Sánchez D, Fibla JJ, Boada M, Hernández J, Guzmán R, Libreros A, Gómez-Caro A, Guerrero C, Agustí A.

Lung Cancer. 2019 Sep;135:230-233. doi: 10.1016/j.lungcan.2019.06.008. Epub 2019 Jun 15.

PMID:
31235316
2.

Clinical significance of long non-coding RNA HOTTIP in early-stage non-small-cell lung cancer.

Navarro A, Moises J, Santasusagna S, Marrades RM, Viñolas N, Castellano JJ, Canals J, Muñoz C, Ramírez J, Molins L, Monzo M.

BMC Pulm Med. 2019 Feb 28;19(1):55. doi: 10.1186/s12890-019-0816-8.

3.

Exosome Analysis in Tumor-Draining Pulmonary Vein Identifies NSCLC Patients with Higher Risk of Relapse after Curative Surgery.

Navarro A, Molins L, Marrades RM, Moises J, Viñolas N, Morales S, Canals J, Castellano JJ, Ramírez J, Monzo M.

Cancers (Basel). 2019 Feb 21;11(2). pii: E249. doi: 10.3390/cancers11020249.

4.

NKX2-1 expression as a prognostic marker in early-stage non-small-cell lung cancer.

Moisés J, Navarro A, Santasusagna S, Viñolas N, Molins L, Ramirez J, Osorio J, Saco A, Castellano JJ, Muñoz C, Morales S, Monzó M, Marrades RM.

BMC Pulm Med. 2017 Dec 13;17(1):197. doi: 10.1186/s12890-017-0542-z.

5.

Cavitating Pulmonary Nodules in a Patient Receiving Anti-TNF.

Martín-de León R, Moisés J, Peris P, Agustí C, Marrades RM.

Arch Bronconeumol. 2018 Aug;54(8):431-432. doi: 10.1016/j.arbres.2017.08.017. Epub 2017 Nov 3. English, Spanish. No abstract available.

6.

LincRNA-p21 Impacts Prognosis in Resected Non-Small Cell Lung Cancer Patients through Angiogenesis Regulation.

Castellano JJ, Navarro A, Viñolas N, Marrades RM, Moises J, Cordeiro A, Saco A, Muñoz C, Fuster D, Molins L, Ramirez J, Monzo M.

J Thorac Oncol. 2016 Dec;11(12):2173-2182. doi: 10.1016/j.jtho.2016.07.015. Epub 2016 Aug 2.

7.

YKT6 expression, exosome release, and survival in non-small cell lung cancer.

Ruiz-Martinez M, Navarro A, Marrades RM, Viñolas N, Santasusagna S, Muñoz C, Ramírez J, Molins L, Monzo M.

Oncotarget. 2016 Aug 9;7(32):51515-51524. doi: 10.18632/oncotarget.9862.

8.

Assessment of a Combined Panel of Six Serum Tumor Markers for Lung Cancer.

Molina R, Marrades RM, Augé JM, Escudero JM, Viñolas N, Reguart N, Ramirez J, Filella X, Molins L, Agustí A.

Am J Respir Crit Care Med. 2016 Feb 15;193(4):427-37. doi: 10.1164/rccm.201404-0603OC.

PMID:
26465739
9.

The significance of PIWI family expression in human lung embryogenesis and non-small cell lung cancer.

Navarro A, Tejero R, Viñolas N, Cordeiro A, Marrades RM, Fuster D, Caritg O, Moises J, Muñoz C, Molins L, Ramirez J, Monzo M.

Oncotarget. 2015 Oct 13;6(31):31544-56. doi: 10.18632/oncotarget.3003.

10.

miR-141 and miR-200c as markers of overall survival in early stage non-small cell lung cancer adenocarcinoma.

Tejero R, Navarro A, Campayo M, Viñolas N, Marrades RM, Cordeiro A, Ruíz-Martínez M, Santasusagna S, Molins L, Ramirez J, Monzó M.

PLoS One. 2014 Jul 8;9(7):e101899. doi: 10.1371/journal.pone.0101899. eCollection 2014.

11.

Low miR-145 and high miR-367 are associated with unfavourable prognosis in resected nonsmall cell lung cancer.

Campayo M, Navarro A, Viñolas N, Diaz T, Tejero R, Gimferrer JM, Molins L, Cabanas ML, Ramirez J, Monzo M, Marrades R.

Eur Respir J. 2013 May;41(5):1172-8. doi: 10.1183/09031936.00048712. Epub 2012 Jul 26.

12.

A dual role for KRT81: a miR-SNP associated with recurrence in non-small-cell lung cancer and a novel marker of squamous cell lung carcinoma.

Campayo M, Navarro A, Viñolas N, Tejero R, Muñoz C, Diaz T, Marrades R, Cabanas ML, Gimferrer JM, Gascon P, Ramirez J, Monzo M.

PLoS One. 2011;6(7):e22509. doi: 10.1371/journal.pone.0022509. Epub 2011 Jul 25.

13.

Prognostic implications of miR-16 expression levels in resected non-small-cell lung cancer.

Navarro A, Diaz T, Gallardo E, Viñolas N, Marrades RM, Gel B, Campayo M, Quera A, Bandres E, Garcia-Foncillas J, Ramirez J, Monzo M.

J Surg Oncol. 2011 Apr;103(5):411-5. doi: 10.1002/jso.21847. Epub 2010 Dec 29.

PMID:
21400525
14.

Single nucleotide polymorphisms in tobacco metabolism and DNA repair genes and prognosis in resected non-small-cell lung cancer.

Campayo M, Viñolas N, Navarro A, Carcereny E, Casas F, Gel B, Diaz T, Gimferrer JM, Marrades RM, Ramirez J, Monzo M.

J Surg Res. 2011 May 1;167(1):e5-12. doi: 10.1016/j.jss.2011.01.007. Epub 2011 Feb 2.

PMID:
21324488
15.

Significance of the presence of lymphocytes in the cytological analysis of transbronchial needle aspiration.

Lucena CM, Agustí C, Martínez-Olondris P, Cano-Jiménez E, Marrades RM, Ramírez J, Sánchez M, Arguis P, Xaubet A.

Arch Bronconeumol. 2011 Mar;47(3):122-7. doi: 10.1016/j.arbres.2010.10.005. Epub 2011 Feb 1. English, Spanish.

16.

Incidence of occult mediastinal node involvement in cN0 non-small-cell lung cancer patients after negative uptake of positron emission tomography/computer tomography scan.

Gómez-Caro A, Garcia S, Reguart N, Arguis P, Sanchez M, Gimferrer JM, Marrades R, Lomeña F.

Eur J Cardiothorac Surg. 2010 May;37(5):1168-74. doi: 10.1016/j.ejcts.2009.12.013. Epub 2010 Jan 29.

PMID:
20116273
17.

miR-34a as a prognostic marker of relapse in surgically resected non-small-cell lung cancer.

Gallardo E, Navarro A, Viñolas N, Marrades RM, Diaz T, Gel B, Quera A, Bandres E, Garcia-Foncillas J, Ramirez J, Monzo M.

Carcinogenesis. 2009 Nov;30(11):1903-9. doi: 10.1093/carcin/bgp219. Epub 2009 Sep 7.

PMID:
19736307
18.

Usefulness of serum tumor markers, including progastrin-releasing peptide, in patients with lung cancer: correlation with histology.

Molina R, Augé JM, Bosch X, Escudero JM, Viñolas N, Marrades R, Ramírez J, Carcereny E, Filella X.

Tumour Biol. 2009;30(3):121-9. doi: 10.1159/000224628. Epub 2009 Jun 9.

PMID:
19506400
19.

A controlled trial of noninvasive ventilation for chronic obstructive pulmonary disease exacerbations.

Carrera M, Marín JM, Antón A, Chiner E, Alonso ML, Masa JF, Marrades R, Sala E, Carrizo S, Giner J, Gomez-Merino E, Teran J, Disdier C, Agustí AG, Barbé F.

J Crit Care. 2009 Sep;24(3):473.e7-14. doi: 10.1016/j.jcrc.2008.08.007. Epub 2009 Jan 17.

PMID:
19327308
20.

MicroRNAs expressed during lung cancer development are expressed in human pseudoglandular lung embryogenesis.

Navarro A, Marrades RM, Viñolas N, Quera A, Agustí C, Huerta A, Ramirez J, Torres A, Monzo M.

Oncology. 2009;76(3):162-9. doi: 10.1159/000201569. Epub 2009 Feb 11.

PMID:
19209007
21.

Mucins CA 125, CA 19.9, CA 15.3 and TAG-72.3 as tumor markers in patients with lung cancer: comparison with CYFRA 21-1, CEA, SCC and NSE.

Molina R, Auge JM, Escudero JM, Marrades R, Viñolas N, Carcereny E, Ramirez J, Filella X.

Tumour Biol. 2008;29(6):371-80. doi: 10.1159/000181180. Epub 2008 Dec 8.

PMID:
19060513
22.

[Transbronchial needle aspiration in the study of mediastinal lymph nodes: yield and cost-effectiveness].

Martínez-Olondris P, Molina-Molina M, Xaubet A, Marrades RM, Luburich P, Ramírez J, Torres A, Agustí C.

Arch Bronconeumol. 2008 Jun;44(6):290-4. Spanish.

23.

Transesophageal ultrasound-guided fine needle aspiration improves mediastinal staging in patients with non-small cell lung cancer and normal mediastinum on computed tomography.

Fernández-Esparrach G, Ginès A, Belda J, Pellisé M, Solé M, Marrades R, Sendino O, Colomo L, Mata A, Llach J, Bordas JM, Castells A.

Lung Cancer. 2006 Oct;54(1):35-40. Epub 2006 Jul 28.

PMID:
16876905
24.

Differences in COPD care among doctors who control the disease: general practitioner vs. pneumologist.

Garcia-Aymerich J, Escarrabill J, Marrades RM, Monsó E, Barreiro E, Antó JM; EFRAM Investigators.

Respir Med. 2006 Feb;100(2):332-9. Epub 2005 Jun 4.

25.

Physical activity and its determinants in severe chronic obstructive pulmonary disease.

Garcia-Aymerich J, Félez MA, Escarrabill J, Marrades RM, Morera J, Elosua R, Antó JM.

Med Sci Sports Exerc. 2004 Oct;36(10):1667-73.

PMID:
15595285
26.

Paradoxical results in the study of risk factors of chronic obstructive pulmonary disease (COPD) re-admission.

Garcia-Aymerich J, Marrades RM, Monsó E, Barreiro E, Farrero E, Antó JM; EFRAM Investigators.

Respir Med. 2004 Sep;98(9):851-7.

27.

[Results of a preventive program and assisted hospital discharge for COPD exacerbation. A feasibility study].

Pascual-Pape T, Badia JR, Marrades RM, Hernández C, Ballester E, Fornas C, Fernández A, Montserrat JM.

Med Clin (Barc). 2003 Mar 29;120(11):408-11. Spanish.

PMID:
12681217
28.

Risk factors of readmission to hospital for a COPD exacerbation: a prospective study.

Garcia-Aymerich J, Farrero E, Félez MA, Izquierdo J, Marrades RM, Antó JM; Estudi del Factors de Risc d'Agudització de la MPOC investigators.

Thorax. 2003 Feb;58(2):100-5.

29.

Health-related quality of life and mortality in male patients with chronic obstructive pulmonary disease.

Domingo-Salvany A, Lamarca R, Ferrer M, Garcia-Aymerich J, Alonso J, Félez M, Khalaf A, Marrades RM, Monsó E, Serra-Batlles J, Antó JM.

Am J Respir Crit Care Med. 2002 Sep 1;166(5):680-5.

PMID:
12204865
30.

Skeletal muscle mitochondrial function is preserved in young patients with chronic renal failure.

Miró O, Marrades RM, Roca J, Sala E, Masanés F, Campistol JM, Torregrosa JV, Casademont J, Wagner PD, Cardellach F.

Am J Kidney Dis. 2002 May;39(5):1025-31.

PMID:
11979346
31.

Risk factors for hospitalization for a chronic obstructive pulmonary disease exacerbation. EFRAM study.

Garcia-Aymerich J, Monsó E, Marrades RM, Escarrabill J, Félez MA, Sunyer J, Antó JM; EFRAM Investigators.

Am J Respir Crit Care Med. 2001 Sep 15;164(6):1002-7.

PMID:
11587986
32.

Is it necessary to treat all patients with idiopathic pulmonary fibrosis?

Xaubet A, Agustí C, Luburich P, Roca J, Ayuso MC, Marrades RM, Rodriguez-Roisin R.

Sarcoidosis Vasc Diffuse Lung Dis. 2001 Oct;18(3):289-95.

PMID:
11587101
33.

Muscle angiogenic growth factor gene responses to exercise in chronic renal failure.

Wagner PD, Masanés F, Wagner H, Sala E, Miró O, Campistol JM, Marrades RM, Casademont J, Torregrosa V, Roca J.

Am J Physiol Regul Integr Comp Physiol. 2001 Aug;281(2):R539-46.

34.

[Hospital-at-home, a new health care approach?].

Marrades R.

Arch Bronconeumol. 2001 Apr;37(4):157-9. Spanish. No abstract available.

35.

Patients hospitalized for COPD have a high prevalence of modifiable risk factors for exacerbation (EFRAM study).

Garcia-Aymerich J, Barreiro E, Farrero E, Marrades RM, Morera J, Antó JM.

Eur Respir J. 2000 Dec;16(6):1037-42.

36.

Impaired muscle oxygen transfer in patients with chronic renal failure.

Sala E, Noyszewski EA, Campistol JM, Marrades RM, Dreha S, Torregrossa JV, Beers JS, Wagner PD, Roca J.

Am J Physiol Regul Integr Comp Physiol. 2001 Apr;280(4):R1240-8.

37.

[COPD and non invasive ventilation].

Marrades RM, Rodríguez Roisin R.

Arch Bronconeumol. 2001 Feb;37(2):88-95. Review. Spanish. No abstract available.

38.

Physiological changes in respiratory function associated with ageing.

Rodriguez-Roisin R, Burgos F, Roca J, Barberà JA, Marrades RM, Wagner PD.

Eur Respir J. 1999 Dec;14(6):1454; author reply 1455-6. No abstract available.

39.

Gas exchange response to a PAF receptor antagonist, SR 27417A, in acute asthma: a pilot study.

Gómez FP, Marrades RM, Iglesia R, Roca J, Barberà JA, Chung KF, Rodriguez-Roisin RM.

Eur Respir J. 1999 Sep;14(3):622-6.

40.

Effects of endurance training on skeletal muscle bioenergetics in chronic obstructive pulmonary disease.

Sala E, Roca J, Marrades RM, Alonso J, Gonzalez De Suso JM, Moreno A, Barberá JA, Nadal J, de Jover L, Rodriguez-Roisin R, Wagner PD.

Am J Respir Crit Care Med. 1999 Jun;159(6):1726-34.

PMID:
10351910
41.

Effects of F(I)O2 on leg VO2 during cycle ergometry in sedentary subjects.

Cardús J, Marrades RM, Roca J, Barberà JA, Diaz O, Masclans JR, Rodriguez-Roisin R, Wagner PD.

Med Sci Sports Exerc. 1998 May;30(5):697-703.

PMID:
9588611
42.

Chronic obstructive pulmonary disease stage and health-related quality of life. The Quality of Life of Chronic Obstructive Pulmonary Disease Study Group.

Ferrer M, Alonso J, Morera J, Marrades RM, Khalaf A, Aguar MC, Plaza V, Prieto L, Antó JM.

Ann Intern Med. 1997 Dec 15;127(12):1072-9.

PMID:
9412309
43.

Increase in pulmonary ventilation-perfusion inequality with age in healthy individuals.

Cardús J, Burgos F, Diaz O, Roca J, Barberà JA, Marrades RM, Rodriguez-Roisin R, Wagner PD.

Am J Respir Crit Care Med. 1997 Aug;156(2 Pt 1):648-53.

PMID:
9279253
44.

Nebulized glutathione induces bronchoconstriction in patients with mild asthma.

Marrades RM, Roca J, Barberà JA, de Jover L, MacNee W, Rodriguez-Roisin R.

Am J Respir Crit Care Med. 1997 Aug;156(2 Pt 1):425-30.

PMID:
9279219
45.

Inhibition of PAF-induced gas exchange defects by beta-adrenergic agonists in mild asthma is not due to bronchodilation.

Díaz O, Barberà JA, Marrades R, Chung KF, Roca J, Rodriguez-Roisin R.

Am J Respir Crit Care Med. 1997 Jul;156(1):17-22.

PMID:
9230720
46.

Adjustment of DLCO for hemoglobin concentration.

Marrades RM, Diaz O, Roca J, Campistol JM, Torregrosa JV, Barberà JA, Cobos A, Félez MA, Rodriguez-Roisin R.

Am J Respir Crit Care Med. 1997 Jan;155(1):236-41.

PMID:
9001318
47.

Validity and reliability of the St George's Respiratory Questionnaire after adaptation to a different language and culture: the Spanish example.

Ferrer M, Alonso J, Prieto L, Plaza V, Monsó E, Marrades R, Aguar MC, Khalaf A, Antó JM.

Eur Respir J. 1996 Jun;9(6):1160-6.

48.

Severe pulmonary infections in AIDS patients.

Gatell JM, Marrades R, el-Ebiary M, Torres A.

Semin Respir Infect. 1996 Jun;11(2):119-28. Review.

PMID:
8776781
49.

Cellular bioenergetics after erythropoietin therapy in chronic renal failure.

Marrades RM, Alonso J, Roca J, González de Suso JM, Campistol JM, Barberá JA, Diaz O, Torregrosa JV, Masclans JR, Rodríguez-Roisin R, Wagner PD.

J Clin Invest. 1996 May 1;97(9):2101-10.

50.

Effects of erythropoietin on muscle O2 transport during exercise in patients with chronic renal failure.

Marrades RM, Roca J, Campistol JM, Diaz O, Barberá JA, Torregrosa JV, Masclans JR, Cobos A, Rodríguez-Roisin R, Wagner PD.

J Clin Invest. 1996 May 1;97(9):2092-100.

Supplemental Content

Loading ...
Support Center